Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Net Asset Quality Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Net Asset Quality Index of 89.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.65 Billion minus total liabilities of CN¥176.07 Million yields net assets of CN¥1.47 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Xinxiang Tuoxin Pharmaceutical Co.Ltd. liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Net Asset Quality Index Over Time (2019–2025)
This chart shows how Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 89.3%, representing net assets of CN¥1.47 Billion against total assets of CN¥1.65 Billion CNY. See working capital position of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.1% | CN¥1.48 Billion | CN¥1.67 Billion | CN¥181.12 Million | ▲ +0.8 pp |
| 2024 | 88.3% | CN¥1.55 Billion | CN¥1.76 Billion | CN¥205.72 Million | ▲ +1.1 pp |
| 2023 | 87.2% | CN¥1.60 Billion | CN¥1.84 Billion | CN¥235.72 Million | ▲ +12.5 pp |
| 2022 | 74.7% | CN¥1.38 Billion | CN¥1.84 Billion | CN¥466.89 Million | ▼ -4.1 pp |
| 2021 | 78.7% | CN¥1.10 Billion | CN¥1.39 Billion | CN¥296.35 Million | ▲ +26.9 pp |
| 2020 | 51.9% | CN¥490.87 Million | CN¥946.48 Million | CN¥455.61 Million | ▲ +0.1 pp |
| 2019 | 51.8% | CN¥383.11 Million | CN¥739.85 Million | CN¥356.74 Million | — |